Background: The greatest challenges in vaccine development include optimization of DNA vaccines for use in humans, creation of effective single-dose vaccines, development of delivery systems that do not involve live viruses, and the identification of effective new adjuvants. Herein, we describe a novel, simple technique for efficiently vaccinating mice against tuberculosis (TB). Our technique consists of a single-dose, genetic vaccine formulation of DNA-hsp65 complexed with cationic liposomes and administered intranasally. Results: We developed a novel and non-toxic formulation of cationic liposomes, in which the DNA-hsp65 vaccine was entrapped (ENTR-hsp65) or complexed (COMP-hsp65), and used to immunize mice by intramuscular or intranasal ...
Despite the vaccine Mycobacterium bovis Bacillus Calmette–Guérin is used worldwide, tuberculosis (TB...
AbstractWe have developed a novel tuberculosis (TB) vaccine; a combination of the DNA vaccines expre...
According to the Global Tuberculosis Report 2014, one third of the world population was latently inf...
Background: The greatest challenges in vaccine development include optimization of DNA vaccines for ...
inflammation ± SD of six mice per group of one of three independent experiments. *p < 0.01 were cons...
Dose of 25 μg). Thirty days after the last dose, mice were challenged intra-tracheally with H37RV an...
The great challenges for researchers working in the field of vaccinology are optimizing DNA vaccines...
Tuberculosis is a major threat to human health. The high disease burden remains unaffected and the a...
<p>Mice were vaccinated with plasmid DNA (pDNA) encoding antigen 85A (Ag85A), Ag85B, or PstS-3...
Of the hundreds of new tuberculosis ( TB) vaccine candidates some have therapeutic value in addition...
(cationic lipid:DNA); E and F represent liposomes complexing DNA at the same molar charge ratio. Bar...
(cationic lipid:DNA); E and F represent liposomes complexing DNA at the same molar charge ratio. Bar...
DNA vaccine may be a promising tool for controlling tuberculosis development. However, vaccines enco...
DNA vaccination has emerged as a powerful approach in the search for a more efficacious vaccine agai...
Genetic immunization is a promising new technology for developing vaccines against tuberculosis that...
Despite the vaccine Mycobacterium bovis Bacillus Calmette–Guérin is used worldwide, tuberculosis (TB...
AbstractWe have developed a novel tuberculosis (TB) vaccine; a combination of the DNA vaccines expre...
According to the Global Tuberculosis Report 2014, one third of the world population was latently inf...
Background: The greatest challenges in vaccine development include optimization of DNA vaccines for ...
inflammation ± SD of six mice per group of one of three independent experiments. *p < 0.01 were cons...
Dose of 25 μg). Thirty days after the last dose, mice were challenged intra-tracheally with H37RV an...
The great challenges for researchers working in the field of vaccinology are optimizing DNA vaccines...
Tuberculosis is a major threat to human health. The high disease burden remains unaffected and the a...
<p>Mice were vaccinated with plasmid DNA (pDNA) encoding antigen 85A (Ag85A), Ag85B, or PstS-3...
Of the hundreds of new tuberculosis ( TB) vaccine candidates some have therapeutic value in addition...
(cationic lipid:DNA); E and F represent liposomes complexing DNA at the same molar charge ratio. Bar...
(cationic lipid:DNA); E and F represent liposomes complexing DNA at the same molar charge ratio. Bar...
DNA vaccine may be a promising tool for controlling tuberculosis development. However, vaccines enco...
DNA vaccination has emerged as a powerful approach in the search for a more efficacious vaccine agai...
Genetic immunization is a promising new technology for developing vaccines against tuberculosis that...
Despite the vaccine Mycobacterium bovis Bacillus Calmette–Guérin is used worldwide, tuberculosis (TB...
AbstractWe have developed a novel tuberculosis (TB) vaccine; a combination of the DNA vaccines expre...
According to the Global Tuberculosis Report 2014, one third of the world population was latently inf...